Post-Capillary Pulmonary Hypertension: Clinical Review

被引:0
|
作者
Riley, Joshua M. [1 ]
Fradin, James J. [2 ]
Russ, Douglas H. [1 ]
Warner, Eric D. [1 ]
Brailovsky, Yevgeniy [3 ]
Rajapreyar, Indranee [3 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Med, Philadelphia, PA 19147 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19147 USA
[3] Thomas Jefferson Univ Hosp, Jefferson Heart Inst, Philadelphia, PA 19147 USA
关键词
pulmonary hypertension; post-capillary; heart failure; advanced heart failure; HFrEF; PRESERVED EJECTION FRACTION; LEFT-VENTRICULAR DYSFUNCTION; HOSPITALIZED HEART-FAILURE; VASCULAR-RESISTANCE; WEDGE PRESSURE; DIASTOLIC DYSFUNCTION; EXERCISE CAPACITY; PROGNOSTIC VALUE; OUTCOMES; MORTALITY;
D O I
10.3390/jcm13020625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) caused by left heart disease, also known as post-capillary PH, is the most common etiology of PH. Left heart disease due to systolic dysfunction or heart failure with preserved ejection fraction, valvular heart disease, and left atrial myopathy due to atrial fibrillation are causes of post-capillary PH. Elevated left-sided filling pressures cause pulmonary venous congestion due to backward transmission of pressures and post-capillary PH. In advanced left-sided heart disease or valvular heart disease, chronic uncontrolled venous congestion may lead to remodeling of the pulmonary arterial system, causing combined pre-capillary and post-capillary PH. The hemodynamic definition of post-capillary PH includes a mean pulmonary arterial pressure > 20 mmHg, pulmonary vascular resistance < 3 Wood units, and pulmonary capillary wedge pressure > 15 mmHg. Echocardiography is important in the identification and management of the underlying cause of post-capillary PH. Management of post-capillary PH is focused on the treatment of the underlying condition. Strategies are geared towards pharmacotherapy and guideline-directed medical therapy for heart failure, surgical or percutaneous management of valvular disorders, and control of modifiable risk factors and comorbid conditions. Referral to centers with advanced heart and pulmonary teams has shown to improve morbidity and mortality. There is emerging interest in the use of targeted agents classically used in pulmonary arterial hypertension, but current data remain limited and conflicting. This review aims to serve as a comprehensive summary of postcapillary PH and its etiologies, pathophysiology, diagnosis, and management, particularly as it pertains to advanced heart failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension
    Federico Luongo
    Cristiano Miotti
    Gianmarco Scoccia
    Silvia Papa
    Giovanna Manzi
    Nadia Cedrone
    Federica Toto
    Claudia Malerba
    Gennaro Papa
    Annalisa Caputo
    Giulia Manguso
    Francesca Adamo
    Dario Vizza Carmine
    Roberto Badagliacca
    Heart Failure Reviews, 2023, 28 : 745 - 755
  • [22] Pulmonary Artery Denervation for Combined Pre- and Post-Capillary Pulmonary Hypertension Hype or Hope?
    Thenappan, Thenappan
    Gomberg-Maitland, Mardi
    JACC-HEART FAILURE, 2023, 11 (08) : 1147 - 1149
  • [23] Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension
    Ghio, Stefano
    Crimi, Gabriele
    Pica, Silvia
    Temporelli, Pier Luigi
    Boffini, Massimo
    Rinaldi, Mauro
    Raineri, Claudia
    Scelsi, Laura
    Pistono, Massimo
    Totaro, Rossana
    Guida, Stefania
    Visconti, Luigi Oltrona
    PLOS ONE, 2017, 12 (11):
  • [24] Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
    Olsson, Karen M.
    Frank, Anika
    Fuge, Jan
    Welte, Tobias
    Hoeper, Marius M.
    Bitter, Thomas
    RESPIRATORY RESEARCH, 2015, 16
  • [25] Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report
    Chomette, L.
    Caravita, S.
    Dewachter, C.
    Abramowicz, M.
    Vachiery, J. L.
    Antoine, Bondue
    PULMONARY CIRCULATION, 2021, 11 (01)
  • [26] Pulmonary Artery Denervation A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?
    Dimopoulos, Konstantinos
    Ernst, Sabine
    McCabe, Colm
    Kempny, Aleksander
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (03) : 285 - 288
  • [27] Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension
    Ghio, Stefano
    Crimi, Gabriele
    Temporelli, Pier Luigi
    Traversi, Egidio
    La Rovere, Maria Teresa
    Cannito, Antonia
    Vizza, Dario
    Scelsi, Laura
    Raineri, Claudia
    Guazzi, Marco
    Visconti, Luigi Oltrona
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (04) : 725 - 734
  • [28] Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines
    Gueder, Guelmisal
    Reiter, Theresa
    Fette, Georg
    Hundertmark, Moritz
    Frantz, Stefan
    Morbach, Caroline
    Stoerk, Stefan
    Held, Matthias
    CLINICAL RESEARCH IN CARDIOLOGY, 2023,
  • [29] Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension
    Arwood, Meghan J.
    Vahabi, Nasim
    Lteif, Christelle
    Sharma, Ravindra K.
    Machado, Roberto F.
    Duarte, Julio D.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] Arterial-ventricular and interventricular interaction in isolated post-capillary and combined pulmonary hypertension in severe mitral stenosis
    Venkateshvaran, Ashwin
    Sola, Srikanth
    Govind, Satish Chandra
    Dash, Pravat Kumar
    Vyavahare, Sagar
    Lund, Lars H.
    la Merkely, Be
    Nagy, Anik Ilona
    Manouras, Aristomenis
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2016, 116 (08) : 1545 - 1554